Emily Kawaler
NYU Langone Health(US)New York University(US)
Publications by Year
Research Areas
Cancer Genomics and Diagnostics, Immune cells in cancer, Cancer Immunotherapy and Biomarkers, Lung Cancer Treatments and Mutations, Histone Deacetylase Inhibitors Research
Most-Cited Works
- → Proteogenomics connects somatic mutations to signalling in breast cancer(2016)1,730 cited
- → Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma(2020)792 cited
- → Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma(2019)754 cited
- → Proteogenomic and metabolomic characterization of human glioblastoma(2021)662 cited
- → Proteogenomic Characterization of Endometrial Carcinoma(2020)515 cited
- → Single-cell RNA sequencing reveals the effects of chemotherapy on human pancreatic adenocarcinoma and its tumor microenvironment(2023)249 cited
- → Proteogenomic integration reveals therapeutic targets in breast cancer xenografts(2017)153 cited
- → Mass Spectrometry–Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast Cancers(2018)59 cited
- Learning to predict post-hospitalization VTE risk from EHR data.(2012)